| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |